Oppenheimer Issues Pessimistic Forecast for Integral Ad Science (NASDAQ:IAS) Stock Price

Integral Ad Science (NASDAQ:IAS) had its target price decreased by equities researchers at Oppenheimer from $20.00 to $18.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price objective indicates a potential upside of 73.58% from the company’s current price.

Other analysts have also issued reports about the company. Morgan Stanley increased their target price on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 23rd. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a report on Monday, August 5th. Raymond James increased their target price on Integral Ad Science from $13.00 to $15.00 and gave the stock an “outperform” rating in a report on Friday, August 2nd. Finally, Barclays increased their target price on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Monday, August 5th. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $15.70.

Integral Ad Science Stock Performance

NASDAQ IAS traded down $0.40 on Wednesday, reaching $10.37. The stock had a trading volume of 170,925 shares, compared to its average volume of 1,385,157. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.76. The firm has a fifty day moving average of $11.11 and a two-hundred day moving average of $10.47. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $17.53. The company has a market cap of $1.69 billion, a P/E ratio of 53.83, a price-to-earnings-growth ratio of 1.46 and a beta of 1.52.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. The firm had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.09) EPS. On average, equities research analysts anticipate that Integral Ad Science will post 0.25 EPS for the current year.

Insider Buying and Selling

In other Integral Ad Science news, CFO Tania Secor sold 5,240 shares of the stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the transaction, the chief financial officer now directly owns 248,223 shares in the company, valued at approximately $2,509,534.53. This trade represents a 2.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the transaction, the chief executive officer now owns 239,709 shares of the company’s stock, valued at $2,423,457.99. This represents a 4.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,006 shares of company stock worth $240,296 in the last ninety days. 2.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Integral Ad Science

Hedge funds have recently made changes to their positions in the stock. nVerses Capital LLC bought a new position in shares of Integral Ad Science during the third quarter worth about $45,000. Ameritas Investment Partners Inc. raised its position in shares of Integral Ad Science by 40.1% during the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock worth $67,000 after acquiring an additional 1,924 shares during the last quarter. Quantbot Technologies LP bought a new position in shares of Integral Ad Science during the third quarter worth about $106,000. Stoneridge Investment Partners LLC bought a new position in shares of Integral Ad Science during the third quarter worth about $125,000. Finally, XTX Topco Ltd bought a new position in shares of Integral Ad Science during the second quarter worth about $113,000. 95.78% of the stock is currently owned by institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.